J.-L. Pierre et al.
FULL PAPER
1.000 cm pathlength quartz cells, connected to an IBM PC 340 micro-
computer. Mass spectra were recorded on a NERMAGR101C mass
spectrometer. Microanalyses were performed by the Central Service of
CNRS, Solaize (France). Melting points were determined with a B¸chi
apparatus and are not corrected. 1H and 13C NMR spectra were obtained in
5 mm tubes at 258C with a Bruker AM 300 or AM 400 spectrometer.
6H; CH2), 3.31 (s, 2H; CH2), 3.39 (s, 3H; CH3), 3.2 3.9 (m, 170H; CH2);
13C NMR (75 MHz, CDCl3): d 12.8 (CH2), 26.2 (CH2), 40.3 (Cq),
59.4(CH3), 68.4 (CH2), 69.7 70.6 (CH2), 120.0 (CN).
Compound 4a: NaOH (506 mg, 12.64 mmol) and hydrazine (99%, 3 mL)
were added to a solution of 3a (1 g, 2.53 mmol) in 95% ethanol (20 mL) at
08C. Raney nickel (445 mg, 7.6 mmol) was added to this mixture in small
portions over 2 h; the solution was stirred for an additional 6 h at room
temperature. The reaction mixture was heated at reflux for 1 h, filtered hot
and evaporated to give a colourless oil. Addition and evaporation of
toluene were repeated until NaOH was precipitated. Evaporation of the
filtrate gave 4a as a colourless oil, which was used without further
purification (938 mg, 2.3 mmol). 1H NMR (300 MHz, [D6]DMSO): d
1.10 1.19 (m, 12H; CH2), 2.44 (m, 6H; CH2), 3.08 (s, 2H; CH2), 3.23 (s,
3H; CH3), 3.39 3.53 (m, 16H; CH2); 13C NMR (75 MHz, [D6]DMSO):
d 27.1 (CH2), 31.6 (CH2), 38.1 (Cq), 42.8 (CH2), 58.1 (CH3), 69.6 71.3
(CH2), 71.3 (CH2), 75.1 (CH2).
Ligand syntheses
Compound 1a: A solution of tetraethylene glycol monomethyl ether (5 g,
24.03 mmol) in THF (7 mL) was added to a solution of NaOH (1.35 g,
33.65 mmol) in water (7 mL). The resulting mixture was cooled to 08C and
a solution of tosyl chloride (4.58 g, 24.03 mmol) in THF (30 mL) was added
over 2 h. The solution was stirred for an additional 2 h at 08C, then
evaporated. The residue was dissolved in water/dichloromethane (50/
100 mL); the organic layer was washed with brine and dried under MgSO4,
and the solvent was removed. The yellow residue was purified by flash
chromatography (silica gel; CH2Cl2). Compound 1a was obtained as a
white oil (8.1 g, 93%) pure enough for the following step. IR (film from
CHCl3): nÄ 1216, 1102 cmÀ1; 1H NMR (300 MHz, CDCl3): d 2.45 (s, 3H;
CH3), 3.37 (s, 3H; CH3), 3.52 3.70 (m, 12H; CH2), 3.68 (t, J 4.9 Hz, 2H;
CH2), 4.15 (t, J 4.9 Hz, 2H; CH2), 7.36 (d, J 8.3 Hz, 2H; ArH), 7.79 (d,
J 8.3 Hz, 2H; ArH); 13C NMR (75 MHz, CDCl3): d 21.5 (CH), 58.8
(CH3), 68.5 (CH2), 69.1 (CH2), 70.35 71.8 (CH2), 127.8 (CH), 129.7 (CH),
132.9 (Cq), 144.7 (Cq).
Compound 4b: Prepared by the synthetic procedure described for 4a, by
using NaOH (853 mg, 21.35 mmol), 3b (1 g, 1.07 mmol) in 95% ethanol
(40 mL), hydrazine 99% (5 mL) and Raney nickel (188 mg, 3.2 mmol).
Compound 4b was obtained as a colourless oil (952 mg, 1 mmol). 1H NMR
(300 MHz, [D6]DMSO): d 1.07 1.23 (m, 12H; CH2), 2.45 (m, 6H; CH2),
3.09 (s, 2H; CH2), 3.29 (s, 3H; CH3), 3.41 3.52 (m, 61H; CH2); 13C NMR
(75 MHz, [D6]DMSO): d 27.1 (CH2), 31.5 (CH2), 38.1 (Cq), 42.8 (CH2),
58.0 (CH3), 60.2 (CH2), 69.6 71.3 (CH2), 71.6 (CH2), 75.1 (CH2).
Compound 1b: Prepared by the synthetic procedure described for 1a, with
poly(ethylene glycol) methyl ether (Acros; average M 750, 20 g,
36.7 mmol) in THF (40 mL), NaOH (1.5 g, 37.3 mmol) in water (8 mL),
and tosyl chloride (5.08 g, 26.7 mmol) in THF (60 mL). Compound 1b was
Compound 4c: Prepared by the synthetic procedure described for 4a, by
using NaOH (1.83 g, 45.72 mmol), 3c (2 g, 0.91 mmol) in 95% ethanol
(80 mL), hydrazine (99%, 10 mL), and Raney nickel (160 mg, 2.7 mmol).
Compound 4b was obtained as a colourless oil (1,91 g, 95%). 1H NMR
(300 MHz, [D6]DMSO): d 1.06 1.23 (m, 12H; CH2), 2.42 (brt, 6H;
CH2), 3.08 (s, 2H; CH2), 3.22 (s, 3H; CH3), 3.34 3.59 (m, 174H; CH2);
13C NMR (75 MHz, [D6]DMSO): d 27.1 (CH2), 31.7 (CH2), 38.1 (Cq), 42.7
(CH2), 58.0 (CH3), 60.9 (CH2), 69.4 71.2 (CH2), 75.1 (CH2).
1
obtained as a white solid (17.6 g, 73%). H NMR (300 MHz, CDCl3): d
2.45 (s, 3H; CH3), 3.38 (s, 3H; CH3), 3.58 3.71 (m, 56H; CH2), 4.16 (t, J
4.8, 2H; CH2), 7.34 (t, J 8.2 Hz, 2H; ArH), 7.79 (t, J 8.2 Hz, 2H; ArH);
13C NMR (75 MHz, CDCl3): d 21.5 (CH3), 58.9 (CH3), 67.3 (CH2), 68.6
(CH2), 69.1 70.6 (CH2), 71.8 (CH2), 72.4 (CH2), 127.9 (CH), 129.7 (CH),
132.9 (Cq), 144.7 (Cq).
Compound 6a (Cox200): Compound 5 (697 mg, 3.68 mmol) was dissolved
in freshly distilled THF (100 mL) under nitrogen and heated at reflux. A
solution of carbonyldiimidazole (656 mg, 4.05 mmol) in dry THF (50 mL)
was added over 30 min. Then a solution of 4a (0.5 g, 1.23 mmol) in dry THF
(50 mL) was added over 30 min. The mixture was stirred overnight and
evaporated. The resulting orange residue was dissolved in chloroform
(150 mL), washed with brine, dried with Na2SO4 and then evaporated to
dryness. The residue was applied to a Sephadex LH-20 column (50%
MeOH CH2Cl2). An orange foam (6a) eluted as a single band (1.42 g,
Compound 1c: Prepared by the synthetic procedure described for 1a, with
poly(ethylene glycol) methyl ether (Aldrich; average M 2000, 30 g,
15 mmol) in THF (60 mL), NaOH (840 mg, 21 mmol) in water (10 mL),
and tosyl chloride (2.86 g, 15 mmol) in THF (40 mL). Compound 1c was
obtained as a white solid (21.97 g, 68%). 1H NMR (300 MHz, CDCl3): d
2.44 (s, 3H; CH3), 3.37 (s, 3H; CH3), 3.4 3.8 (m, 176H; CH2), 4.16 (brt,
2H; CH2), 7.39 (t, J 8.3 Hz, 2H; ArH), 7.80 (t, J 8.3 Hz, 2H; ArH);
13C NMR (75 MHz, CDCl3): d 21.9 (CH3), 59.4 (CH3), 69.0 (CH2), 69.6
72.3 (CH2), 72.9 (CH2), 128.0 (CH), 130.0 (CH), 132.7 (Cq), 144.8 (Cq).
40%). IR (film from CHCl3): nÄ 3460 3200, 1648 cmÀ1
;
1H NMR
Compound 3a: Sodium hydride (429 mg, 60% in paraffin) was washed with
dry pentane and DMSO (5 mL) was added. A solution of 1a in DMSO
(10 mL) was added quickly and the mixture was stirred for 1 h at room
(300 MHz, CDCl3): d 1.35 (m, 6H; CH2), 1.58 (m, 6H; CH2), 3.13 (s,
2H; CH2O), 3.30 (s, 3H; CH3O), 3.35 3.66 (m, 22H; CH2), 7.22 (d, J
8.7 Hz, 3H; ArH), 7.39 (dd, J 7.9 and 4.3 Hz, 3H; ArH), 8.03 (d, J
7.9 Hz, 3H; ArH), 8.10 (d, J 8.7 Hz, 3H; ArH), 8.14 (brs, 3H; NH), 8.78
(d, J 4.3Hz, 3H; ArH), 9.67 (brs, 3H; OH); 13C NMR (70 MHz, CDCl3):
d 22.9 (CH2), 31.4 (CH2), 38.5 (Cq), 40.3 (CH2), 58.7 (CH3O), 70.3 71.7
(CH2), 75.03 (CH2), 113.1 (Cq), 117.1 (CH), 122.9 (CH), 126.1 (CH), 130.13
temperature under
a nitrogen atmosphere. A solution of 2 (3.53 g,
9.74 mmol) in DMSO (10 mL) was added over 15 min and the resulting
mixture was heated to 708C for 18 h. The solution was evaporated and the
resulting yellow oil was dissolved in chloroform, washed with brine, dried
with MgSO4 and then evaporated to dryness. The white residue was
purified by chromatography (silica gel; 2% MeOH in CH2Cl2). Compound
3a was obtained as a colourless oil (2.77 g, 72%) and used without further
(Cq), 135.8 (CH), 138.8 (Cq), 148.4 (CH), 154.1 (COH), 167.1 (C O); MS
(FAB, NBA matrix): m/z: 921 [M1] ; elemental analysis calcd (%) for
C50H60N6O11 ¥ 0.75MeOH ¥ 0.25CH2Cl2: C 61.74, H 6.68, N 8.31; found: C
61.79, H 6.58, N 8.62.
purification. IR (film from CHCl3): nÄ 2248 cmÀ1
;
1H NMR (300 MHz,
CDCl3): d 1.74 (t, J 7.9 Hz, 6H; CH2), 2.42 (t, J 7.9 Hz, 6H; CH2), 3.30
(s, 2 H; CH2), 3.38 (s, 3H; CH3), 3.51 3.70 (m, 16H; CH2); 13C NMR
(75 MHz, CDCl3): d 12.3 (CH2), 26.3 (CH2), 41.0 (Cq), 59.4 (CH3), 68.5
(CH2), 69.1 (CH2), 70.3 70.6 (CH2), 71.5 (CH2), 120.0 (CN).
Compounds 6b (Cox750): Compound 5 (600 mg, 3.16 mmol) was dissolved
in freshly distilled THF (200 mL) under a nitrogen atmosphere and
refluxed. Carbonyldiimidazole (564 mg, 3.48 mmol) in dry THF (20 mL)
was added over 20 min, followed by a solution of 4b (0.5 g, 0.55 mmol) in
dry dichloromethane (200 mL) over 1 h. The mixture was refluxed with
stirring for an additional 48 h and then evaporated. The resulting residue
was applied to a Sephadex LH-20 column (50% MeOH/CH2Cl2). The first
fractions were evaporated and the orange-green residue was applied to a
Compound 3b: Prepared by the synthetic procedure described for 3a, by
using NaH (107 mg, 2.68 mmol), 1b (2 g, 2.2 mmol), 2 (500 mg, 2.43 mmol).
Column chromatography (silica gel; 10% acetone in acetonitrile) afforded
1
3b as a white oil (620 mg, 30%). H NMR (300 MHz, CDCl3): d 1.74 (t,
J 8.1 Hz, 6H; CH2), 2.42 (t, J 8.1 Hz, 6H; CH2), 3.32 (s, 2H; CH2), 3.38
(s, 3 H; CH3), 3.46 3.82 (m, 68H; CH2); 13C NMR (75 MHz, CDCl3): d
12.9 (CH2), 26.6 (CH2), 40.6 (Cq), 59.3 (CH3), 68.6 (CH2), 69.2 (CH2), 70.1
70.9 (CH2), 120.0 (CN).
second column. Compound 6b eluted as
a single band (246 mg,
32%).1H NMR (300 MHz, CDCl3): d 1.32 (m, 6H; CH2), 1.52 (m, 6H;
CH2), 3.01 (m, 6H; CH2), 3.12 (s, 2H; CH2O), 3.29 (s, 3H; CH3O), 3.37
3.60 (m, 68H; CH2), 7.18 (d, J 8.8 Hz, 3H; ArH), 7.37 (m, 3H; ArH), 8.04
(m, 9H; ArH NH), 8.73 (d, J 4.1 Hz, 3H; ArH); 13C NMR (75 MHz,
CDCl3): d 23.0(CH2), 31.5 (CH2), 38.6 (Cq), 40.3 (CH2), 58.8 (CH3O),
69.8 71.8 (CH2), 75.2 (CH2), 113.4 (Cq), 116.4 (CH), 122.9 (CH), 126.5
(CH), 130.1 (Cq), 135.8 (CH), 138.9 (Cq), 148.4 (CH), 154.5 (COH), 166.8
Compound 3c: Prepared by the synthetic procedure described for 3a, by
using NaH (107 mg, 2.68 mmol), 1c (4.72 g, 2.2 mmol) in DMSO (50 mL),
and 2 (500 mg, 2.43 mmol). Column chromatography (silica gel; 10%
acetone in acetonitrile) afforded 3c as a white oil (1 g, 21%). 1H NMR
(300 MHz, CDCl3): d 1.68 (t, J 8.1 Hz, 6H; CH2), 2.26 (t, J 8.1 Hz,
(C O).
1098
¹ WILEY-VCH Verlag GmbH, 69451 Weinheim, Germany, 2002
0947-6539/02/0805-1098 $ 17.50+.50/0
Chem. Eur. J. 2002, 8, No. 5